Summary
A common belief is that one tablet or suppository containing, e.g. 100 mg of a drug can be substituted, without any changes in the therapeutic effect, with two units of the same brand containing 50 mg of the drug. In the present study a single dose of paracetamol was administered to healthy volunteers as (a) two tablets of 500 mg, (b) two suppositories of 500 mg, and (c) one suppository of 1000 mg. There were statistically significant differences in all bioavailability parameters (tmax, Cmax and AUC) between the three treatments. The relative bioavailability of the 500 mg suppositories was 77% and that of the 1000 mg suppositories 66%. The absorption rate from suppositories was markedly lower than from the tablets. Especially low absorption rate was obtained with the suppository of 1000 mg. The two strengths, although having the same trade name, were not therefore bioequivalent.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Shim, C.K., Jung, B.H. (1992): Inter- and intrasubject variations of multiple saliva peaks of acetaminophen after oral administration of tablets. Int. J. Pharm., 82, 233–237.
Shah, V. P., Midha, K.K., Dighe, S., McGilvery, I.J., Skelly, J.P., Yacobi, A., Layloft, T., Viswanathan, C.T., Cook, C.E., McDowall, R.D., Pittman, K.A., Spector, S. (1992): Analytical methods validation; bioavailability, bioequivalence and pharmacokinetic studies. J. Pharm. Sci. 81, 309–312.
Adithan, C., Thangam, J. (1982): A comparative study of saliva and serum paracetamol levels using a simple spectrophotometric method. Br. J. Clin. Pharmacol. 14, 107–109.
Moolenaar, F., Olthof, L., Huizinga, T. (1979): Absorption rate and bioavailability of paracetamol from rectal aqueous suspensions. Pharm. Weekblad. Sci. Ed. 1, 25–30.
Seideman, P., Alvn, G., Andrews, R., Labross, A. (1980): Relative bioavailability of a paracetamol suppository. Eur. J. Clin. Pharmacol. 17, 465–468.
Eandi, M., Viano, I., Ricci Gamalero, S. (1984): Absolute bioavailability of paracetamol after oral and rectal administration in healthy volunteers. Arzneim. Forsch. 43, 903–907.
Blume, H., Ali, S.L., Elze, M., Krämer, J., Wendt, G., Scholz, M.E. (1994): Relative bioverfügbarkeit von paracetamol in suppositorien-zubereitungen im vergleich zu tabletten. Arzneim. Forsch. 44, 1333–138.
Knoben, J.E., Anderson, P.O. (1993): Handbook of clinical drug data. 7th ed. Hamilton: Drug intelligence publication, p. 602.
Ström, C., Forsberg, O., Quiding, H., Engevall, S., Larsson, O. (1990): Analgesic efficacy of acetaminophen sustained release. J. Clin. Pharmacol. 30, 654–659.
Gjellan, K., Graffner, C., Quiding, H. (1994: Influence of amount of hard fat in suppositories on the in vitro release rate and bioavailability of paracetamol and codeine. I. A comparison of three suppository compositions in vivo. Int. J. Pharm. 102, 71–80.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Närvänen, T., Halsas, M., Smal, J. et al. Is one paracetamol suppository of 1000 mg bioequivalent with two suppositories of 500 mg. European Journal of Drug Metabolism and Pharmacokinetics 23, 203–206 (1998). https://doi.org/10.1007/BF03189340
Issue Date:
DOI: https://doi.org/10.1007/BF03189340